The downgrade from Outperform to Neutral by Wedbush indicates a less optimistic outlook for the company's stock. The lowered price target from $240 to $185 also suggests that the analyst believes the stock may not perform as well as previously expected. This could potentially lead to a decrease in the stock's price in the short term.